Table 2. Ranking probability of different kinds of DPP-4is on bone fracture events.
| Treatment | Bone fracture events | |
|---|---|---|
| SUCRA | Rank | |
| Alogliptin | 0.763 | 1 |
| SU | 0.710 | 2 |
| Sitagliptin | 0.679 | 3 |
| SGLT-2 | 0.633 | 4 |
| TZDs | 0.577 | 5 |
| GLP-1RAs | 0.570 | 6 |
| Vildagliptin | 0.403 | 7 |
| Met | 0.403 | 7 |
| Placebo | 0.313 | 9 |
| Linagliptin | 0.231 | 10 |
| Saxagliptin | 0.220 | 11 |
Note: Ranking: probability of being the best treatment, of being the second best, the third best and so on, among the 11 treatments. SUCRA: surface under the cumulative ranking curve. SU: sulphanylureas; SGLT-2: Sodium-Glucose co-Transporter 2; TZDs: thiazolidinediones; GLP-1RAs: including all kinds of glucagon-like peptide-1(GLP-1) receptor agonists; Met: Metformin.